Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,628.00    -94.00 (-1.99%)
Bid:
4,622.00
Ask:
4,628.00
Spread: 6.00 (0.13%)
Market Cap: £17.48b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

17 Dec 2010 07:00

RNS Number : 1449Y
Halma PLC
17 December 2010
 



Halma p.l.c. ('Halma')

 

ACQUISITION OF ACCUDYNAMICS, INC

 

 

Halma, the leading safety, health and sensor technology group, today announces the acquisition of Accudynamics, Inc. ('ADI') on 16 December 2010 for an initial cash consideration of $24.0 million (£15.2 million).

 

ADI is a privately owned business based in Lakeville, Massachusetts, USA and manufactures components primarily for the medical diagnostic system and device markets. Their bespoke products include pumps, fluid handling components and integrated electromechanical assemblies which transport fluids inside their customers' products. ADI will join Halma's Health and Analysis sector within the Fluid Technology group of businesses.

 

Unaudited adjusted accounts for the financial year ended June 2010 show operating profit of $3.7 million (£2.3 million). The initial cash consideration is adjustable $1 for $1 if the completion accounts demonstrate net tangible assets above or below $3.6m (£2.3m). A further $7 million (£4.4 million) is payable based on earnings growth for the period 1 July 2010 to 31 March 2011. The acquisition, which is immediately earnings enhancing, has been funded from Halma's existing cash and debt facilities.

 

Andrew Williams, Halma's Chief Executive, commented:

"ADI is a logical extension of our Fluid Technology sub-sector, enabling us to offer OEM customers integrated sub-assemblies incorporating components from different Halma companies. Following our recent acquisition of Alicat Scientific in November, we have a strong offering for customers requiring precision fluid control in the scientific and medical diagnostic market segments."

 

 

For further information please contact:

 

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

1.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com.

2.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

3.

Exchange rate used: $1.58/£1.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTFBRTMBABBMM
Date   Source Headline
1st Oct 20197:00 amRNSSite Visit
25th Sep 20197:00 amRNSTrading Statement
29th Jul 20199:44 amRNSDirector/PDMR Shareholding
25th Jul 20196:27 pmRNSResult of AGM
25th Jul 20197:00 amRNSNotice of Board Change
15th Jul 201911:01 amRNSHolding(s) in Company
15th Jul 201910:38 amRNSCompletion of Acquisition
4th Jul 20192:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:47 pmRNSDirector/PDMR Shareholding
2nd Jul 201910:34 amRNSHolding(s) in Company
21st Jun 201910:52 amRNSAnnual Financial Report
21st Jun 20197:00 amRNSAcquisition
11th Jun 20197:00 amRNSFinal Results
29th May 20194:00 pmRNSHolding(s) in Company
28th May 201912:59 pmRNSHolding(s) in Company
23rd May 201910:46 amRNSHolding(s) in Company
22nd May 20191:49 pmRNSHolding(s) in Company
21st May 20196:28 pmRNSHolding(s) in Company
17th May 20195:08 pmRNSHolding(s) in Company
13th May 201910:37 amRNSHolding(s) in Company
30th Apr 20199:33 amRNSHolding(s) in Company
17th Apr 201910:13 amRNSHolding(s) in Company
22nd Mar 20199:34 amRNSHolding(s) in Company
21st Mar 201912:30 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSTrading Statement
7th Feb 20192:00 pmRNSInvestor Event
18th Jan 20197:00 amRNSAcquisition
18th Dec 201811:02 amRNSDirector Declaration
20th Nov 20183:21 pmRNSDoc re. Half Year Report
20th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSAcquisition
19th Oct 20187:00 amRNSAcquisition
2nd Oct 20184:39 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSTrading Statement
2nd Aug 20183:29 pmRNSDirector/PDMR Shareholding
1st Aug 20185:23 pmRNSTotal Voting Rights
27th Jul 201810:39 amRNSDirector/PDMR Shareholding
19th Jul 20184:45 pmRNSResult of AGM
4th Jul 201810:25 amRNSDirector/PDMR Shareholding
26th Jun 20186:06 pmRNSDirector Declaration
19th Jun 20185:23 pmRNSAnnual Financial Report
12th Jun 20187:00 amRNSFinal Results
27th Mar 201810:02 amRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSTrading Statement
9th Feb 20183:49 pmRNSDirector/PDMR Shareholding
7th Feb 20182:00 pmRNSInvestor Event
16th Jan 20187:00 amRNSUS Tax Reform Update
21st Dec 20179:00 amRNSAcquisition
5th Dec 201710:10 amRNSDirector/PDMR Shareholding
21st Nov 20173:10 pmRNSDoc re. Half Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.